HIGHLIGHTS
- who: Sheila A. Fisher and colleagues from the Department of Medicine, University of Oxford, Oxford, United Kingdom, Queen Mary University of London CV Biomedical Research Unit, Barts and The London School of have published the research: Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis, in the Journal: PLOS ONE | www.plosone.org of June/19,/2013
- what: For continuous outcomes, the mean change from baseline over the study follow-up period was the preferred measure of outcome; the mean value at . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.